Customereye

Oncologica

Healthcare & Medical • United Kingdomoncologica.com

Review data last updated .

Based on public reviews and response behavior.

Tip: Tap or click the ⓘ icons to learn how to read each section. Expand cards for evidence.

Overall Score

53/100
+9.6 vs. last month4.15 ★ average rating · 600 reviews

Competitive Performance Rank

Among fully-analyzed Healthcare & Medical companies

#350of 615
Top 57% · Mid Pack
#1 (best)#615 (worst)
#348Peer
#349Peer
#350This company
#351Peer
#352Peer

Overall Customer Sentiment

Mid Pack

67% of reviews positive, 31% negative

67%
positive
  • Positive67%
  • Neutral3%
  • Negative31%

Sentiment Balance

Covering September 2022 — 3 reviews, not the company's full review history.

positive
  • Positive
  • Neutral
  • Negative

Takeaway: Positive sentiment accounts for 67% of reviews in this period, with 33% negative and 0% neutral.

Sentiment Trend Over Time

Reviews (Count)

Showing 596 reviews across the months with enough data to chart reliably (min 3/month), most recent: September 2022.

Sentiment has been holding steady over the period shown.

Theme Distribution

Share of theme mentions

Customer Support
20.1%
Response Speed
17.9%
Onboarding
12.6%
Loyalty
11.5%
Delivery Shipping
11.1%

Most feedback concerns Customer Support.

The most common complaint theme is Delivery Shipping, making up 11.1% of all theme mentions.

Churn Signal Score

Rule-based: negative-review share, churn-intent phrases, and sentiment movement over time.

HIGH72/100
72/100
signal score
  • Built from a negative-review share of 49.3% across this company's analyzed reviews.
  • 4 reviews contain phrases that signal intent to leave, such as cancelling or switching provider.
  • Recent reviews are more negative than earlier ones, which pushes the signal up.

Reviewer Breakdown

Star split and recent-versus-earlier sentiment.

4.2avg rating
5
68.7%
4
9.3%
3
4.7%
2
3.0%
1
14.3%

Based on 600 analyzed reviews. Sentiment is slipping: 25.0% of reviews in the last three months were positive, compared with 80.0% in the three months before that.

Unlock full insights

Sign up to view detailed data and analysis